Peptides for Sex drive
The peptides people most often research for sex drive, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 3
- With human trials
- 1
- FDA approved (any use)
- 3
- PT-141Melanocortin agonistHuman RCT evidence, 4 of 4Journal of women's health 2022, PMID 35230162Human42Animal5Summarised9FDA approved for HSDD (Vyleesi)For sex driveOverview
- hCGGonadotropinNo study with an outcome for sex drivePubMed search, 11 Oct 2026Human73Animal20Summarised0FDA approved (prescription only)Overview
- HGHRecombinant growth hormoneNo study with an outcome for sex drivePubMed search, 2 Oct 2026Human13Animal0Summarised0FDA approved (prescription only)For sex driveOverview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What affects sexual desire
MedlinePlus's sexual-health page lists medicines that affect sexual desire or performance among factors that can affect sexual health.[19]
It also says that a number of disorders can affect the ability to have or enjoy sex in both men and women.[19]
PT-141 (bremelanotide) is the one with trials
PubMed records matching the site's sex-drive search: PT-141 42 human-only and 5 animal-only; hCG 73 human-only and 20 animal-only; growth hormone 13 human-only and 0 animal-only.
Calculated from goal sex-drive; ledger date 2026-10-02; counts pt-141 (human only 42, animal 5, rct 9), hcg (human only 73, animal 20, rct 1), hgh (human only 13, animal 0, rct 5). Formula: Copied from web/src/data/goals.json: peptides[].ledger.humanOnly.n and ledger.animal.n for this goal (PubMed title/abstract search, humans[mh] NOT animals vs animals NOT humans).
In two phase 3 trials of women with low desire, bremelanotide raised sexual desire scores more than placebo: 0.30 in study 301, 0.42 in study 302 and 0.35 integrated.[20]
In the same pooled analysis, distress related to low desire fell more than with placebo (-0.37, -0.29 and -0.33 integrated).[20]
In a separate subgroup analysis, bremelanotide improved desire and distress measures across all age, weight and BMI subgroups.[1]
In an earlier trial, vaginal vasocongestion while viewing erotic videos did not change significantly after bremelanotide compared with placebo.[21]
What the FDA label says
Vyleesi is labelled for premenopausal women with acquired, generalized hypoactive sexual desire disorder that causes marked distress and is not due to another medical, psychiatric, relationship or drug cause.[22]
In its phase 3 trials, nausea was reported by 40% of treated patients, required anti-emetic therapy in 13% and led 8% to stop.[22]
The label advises effective contraception during use and stopping if pregnancy is suspected.[22]
Common questions
Is there a peptide that increases sex drive?
Bremelanotide (Vyleesi) is FDA-labelled for premenopausal women with acquired, generalized HSDD; the label says it is not indicated for HSDD in postmenopausal women or in men.[22]
Does PT-141 work for men?
The label says Vyleesi is not indicated in men, and the trials cited here were in women.[22]
How many satisfying sexual events did bremelanotide add?
In a phase 2 trial the pooled doses gave 0.7 versus 0.2 satisfying sexual events per month.[23]
Explore nearby goals
Sources
- 1Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.Journal of women's health (2002) · 2022PMID 35230162Accessed 2 Oct 2026
- 2PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR "male infertility"[tiab] OR hypogonadotropic[tiab] OR testosterone[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (97 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (obesity[tiab] OR "weight loss"[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt] OR systematic review[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (testosterone replacement[tiab] OR TRT[tiab] OR "anabolic steroid"[tiab] OR bodybuilder*[tiab] OR "lean body mass"[tiab] OR "muscle"[tiab]) AND humans[mh] (260 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND men[tiab] NOT pregnan*[tiab] (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt]) (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND ("growth hormone deficiency"[tiab]) AND adult*[tiab] AND randomized controlled trial[pt] (66 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (elderly[tiab] OR "older adults"[tiab] OR healthy[tiab]) AND (systematic review[pt] OR meta-analysis[pt]) (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (athlet*[tiab] OR "physical performance"[tiab] OR "recreational"[tiab]) AND (randomized controlled trial[pt] OR systematic review[pt]) (20 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND sleep[tiab] AND (randomized controlled trial[pt] OR clinical trial[pt]) (12 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (tendon[tiab] OR collagen[tiab] OR "wound healing"[tiab] OR fracture[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR meta-analysis[pt]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (cardiovascular[tiab] OR cardiac[tiab] OR "blood pressure"[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt] OR randomized controlled trial[pt]) (77 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 13PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (diabetes[tiab] OR "insulin resistance"[tiab] OR glucose[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt] OR randomized controlled trial[pt]) (52 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 14PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (skin[tiab] OR hair[tiab] OR aging[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (30 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 15PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND ("sexual function"[tiab] OR libido[tiab] OR "erectile"[tiab] OR "quality of life"[tiab]) AND adult*[tiab] AND (randomized controlled trial[pt] OR meta-analysis[pt]) (29 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 16PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR testosterone[tiab] OR cryptorchidism[tiab] OR "male infertility"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) AND humans[mh] (130 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 17PubMed search: ("chorionic gonadotropin"[tiab] OR hCG[tiab]) AND ("weight loss"[tiab] OR obesity[tiab] OR cryptorchidism[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR thromboembol*[tiab] OR "case report"[pt] OR death[tiab]) (61 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 18PubMed search: ("chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (gynecomastia[tiab] OR "injection site"[tiab] OR hypersensitivity[tiab] OR anaphyla*[tiab]) AND (male[tiab] OR men[tiab] OR boys[tiab]) (95 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 19Official web pageOfficial web page · web page
- 20Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.Obstetrics and gynecology · 2019PMID 31599840Accessed 2 Oct 2026
- 21An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.The journal of sexual medicine · 2006PMID 16839319Accessed 2 Oct 2026
- 22VYLEESI prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 23Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.Women's health (London, England) · 2016PMID 27181790Accessed 2 Oct 2026
Found an error? Report a correction.